In what clinical scenarios is Arista AH indicated?

• A. Indicated for brisk arterial hemorrhage as the first-line therapy.
• B. Indicated only for surgical mucosal cavities with no surface bleeding.
• C. Indicated for diffuse oozing from capillary or venous surfaces or mild arterial bleeding where conventional mechanical methods are insufficient; used as an adjunct to achieve hemostasis; not for brisk arterial hemorrhage.
• D. Indicated for chronic wound infection management.

Answer: (C)

Arista AH is a plant-based, absorbable hemostatic agent designed to help with diffuse oozing from capillary or venous surfaces, and with mild arterial bleeding when conventional mechanical methods aren’t enough. It provides a physical matrix that supports clot formation at the bleeding surface and is used as an adjunct to achieve hemostasis, not as the sole treatment. It should not be relied upon for brisk arterial hemorrhage, which requires definitive mechanical or surgical control. It isn’t intended for situations with no surface bleeding in mucosal cavities, and it’s not a treatment for infection. So the best use is for diffuse oozing or mild arterial bleeding where conventional methods fall short, used alongside other hemostatic techniques.